This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Rural Health
News by Topic: Pharmacy and prescription drugs

Jun 27, 2025 - The Centers for Medicare & Medicaid Services is seeking comment on the following information collections: 1) Medicare Self-Referral Disclosure Protocol; 2) Health Insurance Portability and Accountability Act (HIPAA) Administrative Simplification (Non-Privacy/Security) Complaint Form; and 3) Drug Price Negotiation for Initial Price Applicability Year 2028 under Sections 11001 and 11002 of the Inflation Reduction Act Information Collection Request (ICR). Comments are due by August 26, 2025.
Source: Federal Register
Jun 24, 2025 - Announces new requirements for HRSA-funded health centers to provide insulin and injectable epinephrine to low-income patients at or below the price paid by health centers through the 340B Drug Pricing Program.
Source: Health Resources & Services Administration
May 29, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) making technical corrections to the April 15, 2025, final rule. These corrections are effective May 29, 2025.
Source: Federal Register
May 29, 2025 - The Food and Drug Administration (FDA) has revoked 6 Emergency Use Authorizations issued to Pfizer Inc., MAWD Laboratories, and Nuclein, LLC (merged with Molecular Diagnostics Inc.) related to COVID-19 detection and diagnosis tests.
Source: Federal Register
May 28, 2025 - The Centers for Medicare & Medicaid Services is seeking comments on the following information collections: 1) Application for Part B Immunosuppressive Drug Coverage (Part B-ID); 2) Data Use Agreement (DUA) Limited Data Set (LDS) Forms Research Identifiable Files (RIF) Forms; 3) Comprehensive Outpatient Rehabilitation Facility (CORF) Certification and Survey Forms; and 4) Rural Community Hospital Demonstration Program Application. Comments are due by June 27, 2025.
Source: Federal Register
May 21, 2025 - The Centers for Medicare & Medicaid Services (CMS) is seeking comments on the following information collections: 1) Medicare Part C and Part D Data Validation; 2) Appointment of Representative; 3) Essential Health Benefits in Alternative Benefit Plans, Eligibility Notices, Fair Hearing and Appeal Processes, and Premiums and Cost Sharing; Exchanges: Eligibility and Enrollment; and 4) Affordable Care Act Internal Claims and Appeals and External Review Procedures for Non-grandfathered Group Health Plans and Issuers and Individual Market Issuers. Comments are due by July 21, 2025.
Source: Federal Register
May 21, 2025 - The Food and Drug Administration has revoked Emergency Use Authorizations issued to Fresenius Medical Care North America (Fresenius) multiFiltrate PRO System and multiBic/multiPlus solutions (EUA 048) and to Baxter Healthcare Corp. (Baxter) for REGIOCIT (EUA 068). These revocations are effective January 16, 2025.
Source: Federal Register
May 16, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) making technical and typographic corrections to the December 9, 2024, final rule and the December 30, 2024, correcting amendment. The corrections and correcting amendment are effective May 16, 2025, and applicable beginning January 1, 2025.
Source: Federal Register
May 13, 2025 - The Centers for Medicare & Medicaid Services (CMS) is seeking comments on the following information collections: 1) Medicare Geographic Classification Review Board Procedures and Criteria and 2) Part C and Part D Medicare Prescription Payment Plan Model Documents. Comments are due by July 14, 2025.
Source: Federal Register
May 12, 2025 - The Centers for Medicare & Medicaid Services is seeking comments on the following information collections: 1) Laboratory Personnel Report (CLIA) and Supporting Regulations; 2) End Stage Renal Disease (ESRD) Conditions for Coverage and Supporting Regulations; 3) Hospice Information for Medicare Part D Plans; 4) Part D Coordination of Benefits Data; and 5) Requirements Related to Surprise Billing: Qualifying Payment Amount, Notice and Consent, Disclosure on Patient Protections Against Balance Billing, and State Law Opt-in. Comments are due by June 11, 2025.
Source: Federal Register